热门出版物 - 学术资源搜索

h5 指数:130
h5 中位数:188

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#2 Gastroenterology & Hepatology

标题/作者	引用次数	年份
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension R de Franchis Journal of Hepatology 63 (3), 743-752	1515	2015
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection European Association for the Study of the Liver Journal of Hepatology 67 (2), 370-398	1490	2017
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver Journal of Hepatology 69 (1), 182-236	1118	2018
NAFLD: A multisystem disease CD Byrne, G Targher Journal of Hepatology 62 (1), S47-S64	1055	2015
EASL Recommendations on Treatment of Hepatitis C 2015 European Association for Study of Liver Journal of hepatology 63 (1), 199-236	967	2015
EASL Recommendations on Treatment of Hepatitis C 2016. European Association for the Study of the Liver Journal of hepatology 66 (1), 153	854	2017
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. European Association for the Study of the Liver, ... Journal of hepatology 64 (6), 1388	635	2016
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy M Reig, Z Mariño, C Perelló, M Iñarrairaegui, A Ribeiro, S Lens, A Díaz, ... Journal of Hepatology 65 (4), 719-726	615	2016
EASL Recommendations on Treatment of Hepatitis C 2018 European Association for the Study of the Liver Journal of Hepatology 69 (2), 461-511	613	2018
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals F Conti, F Buonfiglioli, A Scuteri, C Crespi, L Bolondi, P Caraceni, ... Journal of Hepatology 65 (4), 727-733	594	2016
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management S McPherson, T Hardy, E Henderson, AD Burt, CP Day, QM Anstee Journal of Hepatology 62 (5), 1148-1155	568	2015
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites P Angeli, P Ginès, F Wong, M Bernardi, TD Boyer, A Gerbes, R Moreau, ... Journal of Hepatology 62 (4), 968-974	564	2015
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease M Pawlak, P Lefebvre, B Staels Journal of Hepatology 62 (3), 720-733	454	2015
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis G Targher, CD Byrne, A Lonardo, G Zoppini, C Barbui Journal of Hepatology 65 (3), 589-600	409	2016
EASL-ALEH Clinical Practice Guidelines: Non-invasive Tests for Evaluation of Liver Disease Severity and Prognosis European Association for Study of Liver Journal of hepatology 63 (1), 237-264	401	2015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis European Association for the Study of the Liver Journal of Hepatology 69 (2), 406-460	388	2018
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis GR Foster, WL Irving, MCM Cheung, AJ Walker, BE Hudson, S Verma, ... Journal of Hepatology 64 (6), 1224-1231	382	2016
Hepatic fibrosis: Concept to treatment C Trautwein, SL Friedman, D Schuppan, M Pinzani Journal of Hepatology 62 (1), S15-S24	377	2015
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice C Sarrazin Journal of Hepatology 64 (2), 486-504	375	2016
EASL Clinical Practice Guidelines: Autoimmune hepatitis. European Association for the Study of the Liver Journal of hepatology 63 (4), 971	374	2015

1 - 20

计算机程序会自动估算并确定日期和引用次数。